Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Magnetic resonance relaxation refers to microscopic physical mechanisms by which excited nuclear spins return to equilibrium after radiofrequency perturbation in the presence of an external magnetic field. The two most common types are spin-lattice relaxation (T₁), where energy from spins is transferred to their surroundings (the "lattice"), and spin-spin relaxation (T₂), where local interactions cause loss of coherence among spins, leading to signal decay. These processes, driven by dipole-dipole interactions, chemical shift anisotropy, and molecular motion, define how rapidly magnetization returns to equilibrium and how quickly the signal decays, respectively. Relaxation times (T₁, T₂) form the basis for tissue contrast and quantitative mapping in MRI, but are not themselves molecular targets; they report indirect information about molecular and cellular environments in vivo.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Magnetic resonance relaxation.